Literature DB >> 18384559

Alopecia areata in Turkey: demographic and clinical features.

A Kavak1, N Yeşildal, A H Parlak, G Gökdemir, I Aydoğan, H Anul, C Baykal.   

Abstract

BACKGROUND: Alopecia areata is a complex genetic disease with still many unknown aspects, and many studies have been tried to find some clues about it.
OBJECTIVE: We aimed to investigate the demographic and clinical characteristics of alopecia areata in Turkish patients.
METHODS: Demographic data, localization, attack number in addition to some parameters such as disease duration, severity, age of onset, family history and ophiasis pattern were evaluated in 539 alopecia areata patients.
RESULTS: The male to female ratio was 1.6:1. Occipital and beard-moustache areas were mostly affected. Positive family history was noticed in 24.1% of the patients. The age of onset was earlier in women than in men (P = 0.04). Severe forms showed more persistent (> or = 1 year) disease duration (P = 0.00). Ophiasis was more common in severe, long duration (> or = 1 year) and early onset (< or = 18 years) disease (P = 0.00 for all parameters). Childhood alopecia areata (< or = 18 years) was also associated with long duration of the disease (P = 0.016) and positive family history (P = 0.008) when compared with adult onset (> 18 years) alopecia areata.

Entities:  

Mesh:

Year:  2008        PMID: 18384559     DOI: 10.1111/j.1468-3083.2008.02699.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  15 in total

1.  Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathy.

Authors:  Marzia Caproni; Veronica Bonciolini; Antonietta D'Errico; Emiliano Antiga; Paolo Fabbri
Journal:  Gastroenterol Res Pract       Date:  2012-05-30       Impact factor: 2.260

2.  Clinical characteristics and prognostic factors in early-onset alopecia totalis and alopecia universalis.

Authors:  Hyun Hee Cho; Seong Jin Jo; Seung Hwan Paik; Hye Chan Jeon; Kyu Han Kim; Hee Chul Eun; Oh Sang Kwon
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

3.  Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009.

Authors:  Sultan A Mirzoyev; Adam G Schrum; Mark D P Davis; Rochelle R Torgerson
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

4.  An unusual pattern of alopecia areata.

Authors:  Aayush Gupta; Yugal K Sharma; K Dash; Naren Prakash
Journal:  Int J Trichology       Date:  2014-10

5.  Comparative Evaluation of Intralesional Triamcinolone Acetonide Injection, Narrow Band Ultraviolet B, and their Combination in Alopecia Areata.

Authors:  Sandeep Kaur; Bharat Bhushan Mahajan; Raman Mahajan
Journal:  Int J Trichology       Date:  2015 Oct-Dec

6.  Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study.

Authors:  Tugba Kevser Uzuncakmak; Burhan Engin; Server Serdaroglu; Yalcin Tuzun
Journal:  Skin Appendage Disord       Date:  2020-10-28

Review 7.  Epidemiology and burden of alopecia areata: a systematic review.

Authors:  Alexandra C Villasante Fricke; Mariya Miteva
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-07-24

8.  Quality of life in alopecia areata: a sample of tunisian patients.

Authors:  Jawaher Masmoudi; Rim Sellami; Uta Ouali; Leila Mnif; Ines Feki; Mariam Amouri; Hamida Turki; Abdellaziz Jaoua
Journal:  Dermatol Res Pract       Date:  2013-07-18

9.  Videocapillaroscopic alterations in alopecia areata.

Authors:  Agnieszka Gerkowicz; Dorota Krasowska; Aldona Pietrzak; Anna Michalak-Stoma; Joanna Bartosińska; Maria Juszkiewicz-Borowiec; Grażyna Chodorowska
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

10.  Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients.

Authors:  Joong-Woon Choi; Dong-Woo Suh; Bark-Lynn Lew; Woo-Young Sim
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.